{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:18:12Z","timestamp":1790169492593,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jaad.2017.01.036","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T09:45:23Z","timestamp":1505382323000},"page":"607-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Postinflammatory hyperpigmentation: A comprehensive overview"],"prefix":"10.1016","volume":"77","author":[{"given":"Suteeraporn","family":"Chaowattanapanit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narumol","family":"Silpa-archa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indermeet","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.01.036_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-4632.2004.02267.x","article-title":"Postinflammatory hyperpigmentation: a common but troubling condition","volume":"43","author":"Lacz","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib2","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/bjd.14184","article-title":"An in\u00a0vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits","volume":"174","author":"Isedeh","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib3","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms10062440","article-title":"An updated review of tyrosinase inhibitors","volume":"10","author":"Chang","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2017.01.036_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2013.09.048","article-title":"The use of botanically derived agents for hyperpigmentation: a systematic review","volume":"70","author":"Fisk","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib5","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","article-title":"Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients","volume":"328","author":"Bulengo-Ransby","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.01.036_bib6","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib7","first-page":"153","article-title":"Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening","volume":"86","author":"Draelos","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib8","first-page":"917","article-title":"Efficacy of a soy moisturizer in photoaging: a double-blind, vehicle-controlled, 12-week study","volume":"6","author":"Wallo","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/srt.12107","article-title":"Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial","volume":"20","author":"Lee","year":"2014","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.jaad.2017.01.036_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CCID.S39246","article-title":"Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study","volume":"6","author":"Castanedo-Cazares","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1473-2165.2007.00295.x","article-title":"Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine","volume":"6","author":"Bissett","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2133.2009.09477.x","article-title":"Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial","volume":"162","author":"Kimball","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1524-4725.1997.tb00014.x","article-title":"Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study","volume":"23","author":"Burns","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib14","first-page":"362","article-title":"A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation","volume":"74","author":"Grimes","year":"2004","journal-title":"Cutis"},{"issue":"4 suppl","key":"10.1016\/j.jaad.2017.01.036_bib15","first-page":"48","article-title":"Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients","volume":"68","author":"Jacyk","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archderm.1975.01630130042004","article-title":"A new formula for depigmenting human skin","volume":"111","author":"Kligman","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib17","first-page":"586","article-title":"Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study","volume":"10","author":"Kircik","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1473-2165.2010.00527.x","article-title":"Treatment of procedure-related postinflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence in Asian patients: report of five cases","volume":"9","author":"Kim","year":"2010","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib20","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1524-4725.2009.01303.x","article-title":"Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation","volume":"35","author":"Katz","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-4165(91)90186-K","article-title":"Mechanism of inhibition of melanogenesis by hydroquinone","volume":"1073","author":"Palumbo","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaad.2017.01.036_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1529-8019.2007.00144.x","article-title":"Skin lightening preparations and the hydroquinone controversy","volume":"20","author":"Draelos","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.01.036_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.sder.2009.04.001","article-title":"Management of hyperpigmentation in darker racial ethnic groups","volume":"28","author":"Grimes","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib24","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.1965.03090220018004","article-title":"Topical use of hydroquinone for depigmentation","volume":"194","author":"Spencer","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2017.01.036_bib25","first-page":"697","article-title":"A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma","volume":"159","author":"Chan","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib26","first-page":"67","article-title":"Efficacy and safety of a new triple-combination agent for the treatment of facial melasma","volume":"72","author":"Taylor","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib27","first-page":"177","article-title":"Community-based trial of a triple-combination agent for the treatment of facial melasma","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2133.1975.tb05110.x","article-title":"Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams","volume":"93","author":"Findlay","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0190-9622(00)90257-3","article-title":"Exogenous ochronosis","volume":"42","author":"Kramer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4103\/0019-5154.100498","article-title":"Exogenous ochronosis after prolonged use of topical hydroquinone (2%) in a 50-year-old Indian female","volume":"57","author":"Gandhi","year":"2012","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0278-6915(92)90075-V","article-title":"Toxicity and carcinogenicity of hydroquinone in F344\/N rats and B6C3F1 mice","volume":"30","author":"Kari","year":"1992","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaad.2017.01.036_bib32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.01670.x","article-title":"The safety of hydroquinone","volume":"20","author":"Nordlund","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.01.036_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(00)90219-6","article-title":"The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies","volume":"42","author":"Fleischer","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2 suppl 2","key":"10.1016\/j.jaad.2017.01.036_bib34","first-page":"6","article-title":"Postinflammatory hyperpigmentation: evolving combination treatment strategies","volume":"78","author":"Taylor","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1473-2165.2006.00260.x","article-title":"The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups","volume":"5","author":"Draelos","year":"2006","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib36","first-page":"261","article-title":"Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%\/tretinoin 0.01% solution and sunscreen in solar lentigines","volume":"74","author":"Ortonne","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib37","first-page":"319","article-title":"Mequinol 2%\/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines","volume":"74","author":"Jarratt","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1473-2165.2007.00321.x","article-title":"Hyperpigmentation and melasma","volume":"6","author":"Rigopoulos","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib39","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0149-2918(98)80076-3","article-title":"Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients","volume":"20","author":"Lowe","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2017.01.036_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","article-title":"Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid","volume":"25","author":"Lim","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib41","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib42","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2001.01291.x","article-title":"An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway","volume":"116","author":"Paine","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000063359","article-title":"Assessment of topical hypopigmenting agents on solar lentigines of Asian women","volume":"204","author":"Hermanns","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.01.036_bib44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0022-3565(25)12357-4","article-title":"Arbutin: mechanism of its depigmenting action in human melanocyte culture","volume":"276","author":"Maeda","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2017.01.036_bib45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.0906-6705.2005.00337.x","article-title":"DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in\u00a0vivo skin lightening potency","volume":"14","author":"Boissy","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib46","first-page":"337","article-title":"A novel cream formulation containing nicotinamide 4%, arbutin 3%, bisabolol 1%, and retinaldehyde 0.05% for treatment of epidermal melasma","volume":"96","author":"Crocco","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2017.01.036_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","article-title":"Topical liquiritin improves melasma","volume":"39","author":"Amer","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib48","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-4632.2004.02134.x","article-title":"A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma","volume":"43","author":"Espinal-Perez","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1473-2165.2011.00588.x","article-title":"A randomized controlled study to evaluate the depigmenting activity of L-ascorbic acid plus phytic acid-serum vs. placebo on solar lentigines","volume":"10","author":"Khemis","year":"2011","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","article-title":"The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer","volume":"147","author":"Hakozaki","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib51","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1473-2165.2006.00277.x","article-title":"Glucosamine: an ingredient with skin and other benefits","volume":"5","author":"Bissett","year":"2006","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib52","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00266-012-9899-9","article-title":"Treatment of melasma with oral administration of tranexamic acid","volume":"36","author":"Wu","year":"2012","journal-title":"Aesthet Plast Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib53","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/jdv.12209","article-title":"Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial","volume":"28","author":"Li","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.01.036_bib54","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","article-title":"Effect of tranexamic acid on melasma: a clinical trial with histological evaluation","volume":"27","author":"Na","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.01.036_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3126\/kumj.v10i4.10993","article-title":"Oral tranexamic acid for the treatment of melasma","volume":"10","author":"Karn","year":"2012","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"10.1016\/j.jaad.2017.01.036_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jocd.12026","article-title":"Tranexamic acid: an important adjuvant in the treatment of melasma","volume":"12","author":"Tse","year":"2013","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/14764172.2012.685478","article-title":"Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial","volume":"14","author":"Kanechorn Na Ayuthaya","year":"2012","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.jaad.2017.01.036_bib58","first-page":"753","article-title":"Topical tranexamic acid as a promising treatment for melasma","volume":"19","author":"Ebrahimi","year":"2014","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.jaad.2017.01.036_bib59","first-page":"148","article-title":"Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature","volume":"13","author":"Choudhry","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(03)02732-4","article-title":"Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin","volume":"50","author":"Middelkamp-Hup","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib61","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamadermatol.2013.4294","article-title":"A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma","volume":"149","author":"Ahmed","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib62","first-page":"95","article-title":"Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice","volume":"33","author":"Golechha","year":"2012","journal-title":"J Environ Biol"},{"key":"10.1016\/j.jaad.2017.01.036_bib63","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0891-5849(99)00090-8","article-title":"Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol","volume":"27","author":"Packer","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jaad.2017.01.036_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fct.2010.11.045","article-title":"Antioxidant and antityrosinase activity of mulberry (Morus alba L.) twigs and root bark","volume":"49","author":"Chang","year":"2011","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jaad.2017.01.036_bib65","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1021\/jf011703i","article-title":"Antioxidant activity of coffee model systems","volume":"50","author":"Charurin","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jaad.2017.01.036_bib66","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaad.2004.12.044","article-title":"Green tea and the skin","volume":"52","author":"Hsu","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1211\/jpp.61.05.0016","article-title":"Silymarin inhibits melanin synthesis in melanocyte cells","volume":"61","author":"Choo","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jaad.2017.01.036_bib68","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/jf9806762","article-title":"Free radical scavenging activity of grape seed extract and antioxidants by electron spin resonance spectrometry in an H(2)O(2)\/NaOH\/DMSO system","volume":"47","author":"Yamaguchi","year":"1999","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jaad.2017.01.036_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0742-8413(98)10109-3","article-title":"A phenolic antioxidant from the freshwater orchid, Habenaria repens","volume":"122","author":"Johnson","year":"1999","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.jaad.2017.01.036_bib70","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1590\/S0365-05962010000500003","article-title":"Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma","volume":"85","author":"Costa","year":"2010","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib71","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2133.2007.07814.x","article-title":"Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial","volume":"156","author":"Khemis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ptr.1085","article-title":"Treatment of melasma with Pycnogenol","volume":"16","author":"Ni","year":"2002","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaad.2017.01.036_bib73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ptr.1537","article-title":"Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma","volume":"18","author":"Yamakoshi","year":"2004","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaad.2017.01.036_bib74","first-page":"82","article-title":"Chemical peeling\u2014glycolic acid versus trichloroacetic acid in melasma","volume":"67","author":"Kalla","year":"2001","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2017.01.036_bib75","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","article-title":"Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser","volume":"20","author":"Taylor","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2017.01.036_bib76","first-page":"59","article-title":"Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design","volume":"29","author":"Angsuwarangsee","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sder.2012.03.001","article-title":"New horizons in treating disorders of hyperpigmentation in skin of color","volume":"31","author":"Konda","year":"2012","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib78","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1524-4725.2000.99268.x","article-title":"Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation","volume":"26","author":"Tafazzoli","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1524-4725.2009.01383.x","article-title":"Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians","volume":"36","author":"Wattanakrai","year":"2010","journal-title":"Dermatol Surg"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2017.01.036_bib80","first-page":"AB215","article-title":"Evaluation and effectiveness of a photoprotection composition (sunscreen) on subjects of skin of color [abstract]","volume":"72","author":"Halder","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib81","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/jid.2010.95","article-title":"Impact of long-wavelength UVA and visible light on melanocompetent skin","volume":"130","author":"Mahmoud","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/phpp.12086","article-title":"Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial","volume":"30","author":"Castanedo-Cazares","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2017.01.036_bib83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2014.08.023","article-title":"Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial","volume":"72","author":"Boukari","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.01.036_bib84","first-page":"654","article-title":"Ten tips for treating acne vulgaris in Fitzpatrick skin types IV-VI","volume":"10","author":"Spann","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2017.01.036_bib85","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jdv.12050","article-title":"A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians","volume":"27","author":"Eimpunth","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.01.036_bib86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/lsm.20512","article-title":"The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians","volume":"39","author":"Chan","year":"2007","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2017.01.036_bib87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1524-4725.1999.08123.x","article-title":"Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing","volume":"25","author":"West","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.01.036_bib88","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-3083.2011.04385.x","article-title":"Comparative study of treatment efficacy and the incidence of post-inflammatory hyperpigmentation with different degrees of irradiation using two different quality-switched lasers for removing solar lentigines on Asian skin","volume":"27","author":"Negishi","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.01.036_bib89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1096-9101(2000)26:2<130::AID-LSM4>3.0.CO;2-J","article-title":"Evaluation of cooling methods for laser dermatology","volume":"26","author":"Zenzie","year":"2000","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2017.01.036_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2340\/00015555-1899","article-title":"Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians","volume":"95","author":"Cheyasak","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.01.036_bib91","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/jdv.12332","article-title":"The use of sunscreen starting on the first day after ablative fractional skin resurfacing","volume":"28","author":"Wanitphakdeedecha","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217301299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217301299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:44:01Z","timestamp":1759272241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217301299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0190962217301299"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.01.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postinflammatory hyperpigmentation: A comprehensive overview","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(17)32275-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}